US5069911A
(en)
*
|
1985-02-05 |
1991-12-03 |
Sandoz Ltd. |
Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
|
US6468561B1
(en)
*
|
1986-06-19 |
2002-10-22 |
Bpsi Holdings, Inc. |
Aqueous film coating with improved properties
|
EP0261719A3
(de)
*
|
1986-09-23 |
1990-10-10 |
Akzo N.V. |
Thermochemischlumineszierende Komplexe von Cyclodextrinen
|
YU43290B
(en)
*
|
1986-11-13 |
1989-06-30 |
Lek Tovarna Farmacevtskih |
Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine
|
NZ225045A
(en)
*
|
1987-07-01 |
1990-06-26 |
Janssen Pharmaceutica Nv |
Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
|
US5068226A
(en)
*
|
1987-12-07 |
1991-11-26 |
Cyclex, Inc. |
Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
|
US5017566A
(en)
*
|
1987-12-30 |
1991-05-21 |
University Of Florida |
Redox systems for brain-targeted drug delivery
|
US5002935A
(en)
*
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
YU45837B
(sh)
*
|
1988-01-18 |
1992-07-20 |
LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. |
Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom
|
US5637575A
(en)
*
|
1988-01-19 |
1997-06-10 |
The Trustees Of The University Of Pennsylvania |
Methods of inhibiting restenosis
|
US5658894A
(en)
*
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
US5019562A
(en)
*
|
1988-01-19 |
1991-05-28 |
The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation |
Growth inhibiting agent and the use thereof
|
US5760015A
(en)
*
|
1988-01-19 |
1998-06-02 |
The Trustees Of The University Of Pennsylvania |
Cyclodextrin compounds and methods of making and use thereof
|
CA1321192C
(en)
*
|
1988-04-20 |
1993-08-10 |
Abdul Majid |
Inclusion complexes of cyclodextrins by agglomeration
|
DE3815902A1
(de)
*
|
1988-05-10 |
1989-11-23 |
Schwarz Pharma Gmbh |
Einschlussverbindungen des 1-(4-(2-(5-chloro-2-methoxybenzamido)ethyl) -phenylsulfonyl)-3-cyclohexylharnstoffs mit (alpha)-,ss-,(gamma)-cyclodextrinen, jeweils diese enthaltendes pharmazeutisches praeparat und verfahren zu deren herstellung
|
GB8813064D0
(en)
|
1988-06-02 |
1988-07-06 |
Euro Celtique Sa |
Controlled release dosage forms having defined water content
|
JPH01308232A
(ja)
*
|
1988-06-03 |
1989-12-12 |
Takeda Chem Ind Ltd |
固型医薬およびその製造法
|
GB8813682D0
(en)
*
|
1988-06-09 |
1988-07-13 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions
|
GB8814726D0
(en)
*
|
1988-06-21 |
1988-07-27 |
Glaxo Group Ltd |
Medicaments
|
US5229370A
(en)
*
|
1988-08-15 |
1993-07-20 |
Ammeraal Robert N |
Water soluble branched beta cyclodextrin steroid complex
|
EP0381747A4
(en)
*
|
1988-08-15 |
1991-09-11 |
American Maize-Products Company |
Water soluble branched beta cyclodextrin steroid complex
|
JPH082781B2
(ja)
*
|
1988-10-18 |
1996-01-17 |
嘉明 川島 |
中空顆粒状医薬及びその製法
|
AU616571B2
(en)
*
|
1988-10-28 |
1991-10-31 |
Shiseido Company Ltd. |
Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
|
US5068227A
(en)
*
|
1989-01-18 |
1991-11-26 |
Cyclex, Inc. |
Cyclodextrins as carriers
|
DE3933000A1
(de)
*
|
1989-10-03 |
1991-04-11 |
Int Pharma Agentur |
Erosionsgesteuertes wirkstoff-freigabesystem und verfahren zu seiner herstellung
|
IT1229517B
(it)
*
|
1989-01-31 |
1991-09-03 |
Bioresearch Spa |
Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
|
US5441944A
(en)
*
|
1989-04-23 |
1995-08-15 |
The Trustees Of The University Of Pennsylvania |
Substituted cyclodextrin sulfates and their uses as growth modulating agents
|
FR2647343B1
(fr)
*
|
1989-05-24 |
1994-05-06 |
Rhone Poulenc Sante |
Nouvelle forme pharmaceutique poreuse et sa preparation
|
FR2647304B1
(fr)
*
|
1989-05-29 |
1994-07-08 |
Roquette Freres |
Composition phytosanitaire, son procede de preparation et son utilisation, en particulier pour lutter contre le mildiou de la vigne
|
DK169306B1
(da)
*
|
1989-06-14 |
1994-10-10 |
Af 18 Juni 1990 As |
Middel til fjernelse eller inaktivering af uønskede komponenter i blod eller andre ekstracellulære legemsvæsker samt fremgangsmåde til fremstilling af dextran-O-carbonyl-benzo-18-crown-6 og af dextran-hydroxyethylbenzo-18-crown-6
|
IT1241673B
(it)
*
|
1989-10-09 |
1994-01-27 |
Istituto Biochimico Italiano |
Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
|
US4983399A
(en)
*
|
1989-10-18 |
1991-01-08 |
Eastman Kodak Company |
Direct compression carrier composition
|
IE63986B1
(en)
*
|
1989-12-30 |
1995-06-28 |
Akzo Nv |
Pharmaceutical preparation for oral administration in fluid form
|
HU210921B
(en)
*
|
1990-03-28 |
1995-09-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
|
HU212730B
(en)
*
|
1990-03-28 |
1996-10-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them
|
US5246611A
(en)
*
|
1990-05-09 |
1993-09-21 |
The Procter & Gamble Company |
Non-destructive carriers for cyclodextrin complexes
|
US5384186A
(en)
*
|
1990-05-09 |
1995-01-24 |
The Proctor & Gamble Company |
Non-destructive carriers for cyclodextrin complexes
|
ES2023552A6
(es)
*
|
1990-05-22 |
1992-01-16 |
Leetrim Limited |
Procedimiento para la preparacion de compuestos de inclusion de nimesulida con ciclodextrina.
|
FR2665158B1
(fr)
*
|
1990-07-30 |
1993-12-24 |
Air Liquide |
Clathrates de peroxyacides.
|
US5180716A
(en)
*
|
1990-08-01 |
1993-01-19 |
The Regents Of The University Of California |
Cyclodextrin complexes for neuraxial administration of drugs
|
IT1243192B
(it)
*
|
1990-08-09 |
1994-05-24 |
Staroil Ltd |
Complessi di acidi grassi polinsaturi a lunga catena e di loro derivati, con ciclodestrine
|
US5292520A
(en)
*
|
1990-09-13 |
1994-03-08 |
Akzo N.V. |
Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
|
US5238927A
(en)
*
|
1990-11-30 |
1993-08-24 |
Brown Nesbitt D |
Hydrolytic stabilizer for unstable organic ions
|
US5258370A
(en)
*
|
1991-04-04 |
1993-11-02 |
Curators Of The University Of Missouri |
Artificial redox enzymes
|
JP2538134B2
(ja)
*
|
1991-04-08 |
1996-09-25 |
田辺製薬株式会社 |
徐放性製剤およびその製造法
|
US5321014A
(en)
*
|
1991-06-28 |
1994-06-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells
|
US5164379A
(en)
*
|
1991-07-15 |
1992-11-17 |
Bristol-Myers Company |
Sucralfate/cyclodextrin complexes
|
AT400674B
(de)
*
|
1991-07-24 |
1996-02-26 |
Biochemie Gmbh |
Pharmazeutische pleuromutilin-zubereitung
|
US5446030A
(en)
*
|
1991-09-19 |
1995-08-29 |
Weisz; Paul B. |
Prevention of hemolysis
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
DE4204315A1
(de)
*
|
1992-02-13 |
1993-08-19 |
Consortium Elektrochem Ind |
Cyclodextringlycoside und verfahren zu ihrer herstellung
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
HU209251B
(en)
*
|
1992-03-13 |
1994-04-28 |
Synepos Ag |
Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
|
US5472954A
(en)
*
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
US5324718A
(en)
*
|
1992-07-14 |
1994-06-28 |
Thorsteinn Loftsson |
Cyclodextrin/drug complexation
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
CN1039585C
(zh)
*
|
1993-01-01 |
1998-08-26 |
生化企业 |
截短侧耳素衍生物与环糊精的配合物和含有它的药物制剂
|
USRE39300E1
(en)
|
1993-01-28 |
2006-09-19 |
Virginia Commonwealth University Medical College Of Virginia |
Inhibiting the development of tolerance to and/or dependence on an addictive substance
|
US5321012A
(en)
*
|
1993-01-28 |
1994-06-14 |
Virginia Commonwealth University Medical College |
Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
|
US5362860A
(en)
*
|
1993-02-01 |
1994-11-08 |
Warner-Lambert Company |
Neutral stabilization complex for CI-979 HCl, a cognition activator
|
US5651983A
(en)
*
|
1993-02-26 |
1997-07-29 |
The Procter & Gamble Company |
Bisacodyl dosage form for colonic delivery
|
BR9405836A
(pt)
*
|
1993-02-26 |
1996-01-16 |
Procter & Gamble |
Forma de dosagem de bisacodil
|
US5914132A
(en)
*
|
1993-02-26 |
1999-06-22 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
US5843479A
(en)
*
|
1993-02-26 |
1998-12-01 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
US5656290A
(en)
*
|
1993-02-26 |
1997-08-12 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
ES2194867T3
(es)
*
|
1993-03-26 |
2003-12-01 |
Franciscus Wilhelmus He Merkus |
Composiciones farmaceuticas para la administracion intranasal de apomorfina.
|
CA2159717A1
(en)
*
|
1993-03-31 |
1994-10-13 |
Elliot Barnathan |
Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
|
NZ260408A
(en)
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US20060263428A1
(en)
*
|
1993-09-20 |
2006-11-23 |
Eugenio Cefali |
Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
|
US6676967B1
(en)
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US6129930A
(en)
|
1993-09-20 |
2000-10-10 |
Bova; David J. |
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
|
US6080428A
(en)
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
KR100354702B1
(ko)
*
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
US5516524A
(en)
*
|
1993-12-20 |
1996-05-14 |
The Procter & Gamble Company |
Laxative compositions containing bulk fiber
|
US5480975A
(en)
*
|
1994-02-08 |
1996-01-02 |
Brigham And Women's Hospital |
Induction of vascular endothelial growth factor (VEGF) by transition metals
|
RU2139051C1
(ru)
*
|
1994-03-02 |
1999-10-10 |
Акцо Нобель Н.В. |
Сублингвальная или трансбуккальная фармацевтическая композиция
|
EP0672416A1
(de)
*
|
1994-03-14 |
1995-09-20 |
Euro-Celtique S.A. |
Diamorphin enthaltendes Arzneimittel
|
US5843480A
(en)
*
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
US5938990A
(en)
*
|
1994-07-01 |
1999-08-17 |
Roche Vitamins Inc. |
Encapsulation of oleophilic substances and compositions produced thereby
|
DE4432757A1
(de)
*
|
1994-09-14 |
1996-03-21 |
Boehringer Mannheim Gmbh |
Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
|
GB9422154D0
(en)
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US20020006438A1
(en)
*
|
1998-09-25 |
2002-01-17 |
Benjamin Oshlack |
Sustained release hydromorphone formulations exhibiting bimodal characteristics
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US5904935A
(en)
*
|
1995-06-07 |
1999-05-18 |
Alza Corporation |
Peptide/protein suspending formulations
|
US5931809A
(en)
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
US5744154A
(en)
*
|
1995-09-06 |
1998-04-28 |
Laboratoire Chauvin S.A. |
Ready-to-use indomethacin-based eye lotion
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
IT1276130B1
(it)
|
1995-11-14 |
1997-10-27 |
Gentili Ist Spa |
Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
|
HUT75956A
(en)
*
|
1995-11-29 |
1997-05-28 |
Cyclolab |
Pharmaceutical composition containing thyroxine
|
US5942501A
(en)
*
|
1996-08-16 |
1999-08-24 |
Collaborative Laboratories, Inc. |
Cyclodextrin derivative complex
|
JP2001503406A
(ja)
*
|
1996-10-28 |
2001-03-13 |
ファーマーク、ニーダーランド、ベスローテン、フェンノートシャップ |
医薬組成物
|
US20060002959A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Government Of The United States |
Skin-sctive adjuvants for transcutaneous immuization
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
US6797276B1
(en)
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
JP2000510874A
(ja)
*
|
1997-03-11 |
2000-08-22 |
ヘクサル アーゲー |
バルプロン酸ナトリウム塩の固体、非潮解性処方物
|
US6046177A
(en)
*
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
US6074674A
(en)
*
|
1997-10-31 |
2000-06-13 |
University Of Kentucky Research Foundation |
Formulations for sustained-release of topical anesthetics and methods of making and using same
|
US20040258703A1
(en)
*
|
1997-11-14 |
2004-12-23 |
The Government Of The Us, As Represented By The Secretary Of The Army |
Skin-active adjuvants for transcutaneous immunization
|
KR100417490B1
(ko)
*
|
1997-12-22 |
2004-02-05 |
유로-셀티크 소시에떼 아노뉨 |
오피오이드 제형의 남용을 방지하는 방법
|
PT1685839E
(pt)
|
1997-12-22 |
2013-07-08 |
Euro Celtique Sa |
Forma de dosagem farmacêutica por via oral compreendendo uma combinação de um agonista opióide e de um antagonista opióide
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
WO2000061184A2
(en)
*
|
1999-04-08 |
2000-10-19 |
Glenn Gregory M |
Dry formulation for transcutaneous immunization
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
KR20130010512A
(ko)
|
1999-10-29 |
2013-01-28 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
TWI242015B
(en)
|
1999-11-29 |
2005-10-21 |
Akzo Nobel Nv |
6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
|
AU776904B2
(en)
|
2000-02-08 |
2004-09-23 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
SK282717B6
(sk)
*
|
2000-03-10 |
2002-11-06 |
�Stav Experiment�Lnej Farmakol�Gie Sav |
Spôsob prípravy ultravysokomolekulových hyalurónanov
|
US6635277B2
(en)
|
2000-04-12 |
2003-10-21 |
Wockhardt Limited |
Composition for pulsatile delivery of diltiazem and process of manufacture
|
US6676966B1
(en)
|
2000-05-09 |
2004-01-13 |
Intellipharmaceutics Corp. |
Extended release metformin hydrochloride formulations
|
US6855721B1
(en)
|
2000-07-28 |
2005-02-15 |
Indevus Pharmaceuticals, Inc. |
Methods and compositions for alleviating stuttering
|
SE0003125D0
(sv)
*
|
2000-09-05 |
2000-09-05 |
Astrazeneca Ab |
Modified polymers
|
KR100960200B1
(ko)
|
2000-10-30 |
2010-05-27 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
AU2002220248A1
(en)
*
|
2000-11-06 |
2002-05-15 |
Andrx Pharmaceuticals, Inc. |
Once a day antihistamine and decongestant formulation
|
EP1372708B1
(de)
*
|
2001-02-13 |
2008-06-18 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY |
Impstoffe zur transkutanen immunisierung gegen reisediarrhö
|
BR0102252B1
(pt)
*
|
2001-04-10 |
2013-10-22 |
|
Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
DE60238756D1
(de)
|
2001-05-11 |
2011-02-10 |
Endo Pharmaceuticals Inc |
Opioid enthaltende arzneiform gegen missbrauch
|
WO2002094324A1
(en)
*
|
2001-05-18 |
2002-11-28 |
Institute Of Materials Research & Engineering |
Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
|
US7052706B2
(en)
*
|
2001-06-08 |
2006-05-30 |
Nostrum Pharmaceuticals, Inc. |
Control release formulation containing a hydrophobic material as the sustained release agent
|
US6524618B1
(en)
|
2001-06-12 |
2003-02-25 |
Vijai Kumar |
Directly compressible extended-release matrix formulation for metformin hydrochloride
|
WO2003007802A2
(en)
*
|
2001-07-18 |
2003-01-30 |
Euro-Celtique, S.A. |
Pharmaceutical combinations of oxycodone and naloxone
|
JP4504013B2
(ja)
|
2001-08-06 |
2010-07-14 |
ユーロ−セルティーク エス.エイ. |
放出可能な及び封鎖されたアンタゴニストを有するオピオイドアゴニスト製剤
|
AU2002324624A1
(en)
*
|
2001-08-06 |
2003-02-24 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
US20030044458A1
(en)
*
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
MXPA04003807A
(es)
*
|
2001-11-30 |
2004-07-30 |
Pfizer Prod Inc |
Formulaciones farmaceuticas de 5, 7, 14-trianzatetraciclo [10.3.1.02, 11, 04, 9]-hexadeca -2 (11), 3, 5, 7, 9-pentaeno.
|
DE20308437U1
(de)
|
2002-04-05 |
2003-11-13 |
Euroceltique S.A., Luxemburg/Luxembourg |
Matrix zur verzögerten, gleichbleibenden und unabhängigen Freisetzung von Wirkstoffen
|
WO2003105809A1
(en)
|
2002-06-17 |
2003-12-24 |
Themis Laboratories Private Limited |
Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
ATE373472T1
(de)
*
|
2002-07-29 |
2007-10-15 |
Alza Corp |
Verfahren und dosierformen für die kontrollierte abgabe von paliperidon
|
EP1549296A4
(de)
|
2002-08-02 |
2006-08-09 |
Penwest Pharmaceuticals Co |
Metformin-formulierungen mit verzögerter freisetzung
|
EP2422775A3
(de)
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Sequestriermitteluntereinheit und zugehörige Zusammensetzungen und Verfahren
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
US8092831B2
(en)
*
|
2002-11-08 |
2012-01-10 |
Andrx Pharmaceuticals, Llc |
Antihistamine and decongestant system
|
US20040156893A1
(en)
*
|
2003-02-11 |
2004-08-12 |
Irwin Klein |
Method for treating hypothyroidism
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
MY135852A
(en)
*
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
EP1575565B1
(de)
*
|
2003-08-08 |
2010-01-06 |
Biovail Laboratories International Srl |
Tablette mit modifizierter freisetzung von bupropion hydrochlorid
|
US20050202079A1
(en)
*
|
2004-03-15 |
2005-09-15 |
Mylan Pharmaceuticals Inc. |
Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
|
GB0408308D0
(en)
|
2004-04-14 |
2004-05-19 |
Vectura Ltd |
Pharmaceutical compositions
|
RU2388466C2
(ru)
|
2004-04-27 |
2010-05-10 |
Медисинова, Инк. |
Производные феноксиалкилкарбоновых кислот при лечении воспалительных заболеваний
|
US7691874B2
(en)
*
|
2004-05-14 |
2010-04-06 |
Hyoung-Chun KIM |
Neuroprotective properties of dextrorotatory morphinans
|
EP1604666A1
(de)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
|
AU2005265412B2
(en)
*
|
2004-07-19 |
2010-09-02 |
Onconova Therapeutics, Inc. |
Formulations for parenteral administration of (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones
|
EP1702558A1
(de)
*
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Verfahren und Vorrichtung zur Darmtätigkeitserfassung
|
WO2007016201A2
(en)
*
|
2005-07-29 |
2007-02-08 |
Onconova Therapeutics, Inc. |
FORMULATION OF RADIOPROTECTIVE α, β UNSATURATED ARYL SULFONES
|
JP4783098B2
(ja)
*
|
2005-09-09 |
2011-09-28 |
リンテック株式会社 |
擬ポリロタキサンおよびポリロタキサンの製造方法
|
US20070281017A1
(en)
*
|
2006-06-06 |
2007-12-06 |
Endo Pharmaceuticals Inc., A Delaware Corporation |
Sustained release oxycodone composition with acrylic polymer and metal hydroxide
|
SI2484346T1
(sl)
|
2006-06-19 |
2017-05-31 |
Alpharma Pharmaceuticals Llc |
Farmacevtski sestavki
|
US20080069871A1
(en)
*
|
2006-07-21 |
2008-03-20 |
Vaughn Jason M |
Hydrophobic abuse deterrent delivery system
|
WO2008105808A2
(en)
*
|
2006-07-28 |
2008-09-04 |
Onconova Therapeutics, Inc. |
FORMULATIONS OF RADIOPROTECTIVE α, β UNSATURATED ARYL SULFONES
|
US20080026054A1
(en)
*
|
2007-04-27 |
2008-01-31 |
Nectid Inc. |
Novel anelgesic combination
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
MX2008004267A
(es)
*
|
2008-03-28 |
2009-09-28 |
Posi Visionary Solutions Llp |
Metoclopramida de liberacion prolongada de 12 horas.
|
MX2008004268A
(es)
*
|
2008-03-28 |
2009-09-28 |
Posi Visionary Solutions Llp |
Metoclopramida de liberacion prolongada de 24 horas.
|
MY150600A
(en)
*
|
2008-07-07 |
2014-01-30 |
Euro Celtique Sa |
Use of opioid antagonists for treating urinary retention
|
PT2405915T
(pt)
|
2009-03-10 |
2019-01-29 |
Euro Celtique Sa |
Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona
|
CA2692211C
(en)
*
|
2009-12-14 |
2011-09-13 |
Cellresin Technologies, Llc |
Maturation or ripening inhibitor release from polymer, fiber, film, sheet or packaging
|
GB2492284B
(en)
|
2011-03-27 |
2013-07-17 |
Cellresin Tech Llc |
Cyclodextrin compositions, articles, and methods
|
US10182567B2
(en)
|
2011-03-27 |
2019-01-22 |
Cellresin Technologies, Llc |
Cyclodextrin compositions, articles, and methods
|
US8962687B2
(en)
|
2012-12-05 |
2015-02-24 |
Medicinova, Inc. |
Method of treating liver disorders
|
US8835499B2
(en)
|
2011-12-08 |
2014-09-16 |
Medicinova, Inc. |
Method of treating non-alcoholic fatty liver disease and steatohepatitis
|
US9320288B2
(en)
|
2012-11-30 |
2016-04-26 |
Cellresin Technologies, Llc |
Controlled release compositions and methods of using
|
NZ716267A
(en)
|
2013-07-23 |
2017-05-26 |
Euro Celtique Sa |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
US20150031769A1
(en)
|
2013-07-25 |
2015-01-29 |
Medicinova, Inc. |
Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels
|
US20150321989A1
(en)
|
2014-05-08 |
2015-11-12 |
Medicinova, Inc. |
Method of treating idiopathic pulmonary fibrosis
|
US9346754B2
(en)
|
2014-05-08 |
2016-05-24 |
Medicinova, Inc. |
Method of treating advanced non-alcoholic steatohepatitis
|
KR102435793B1
(ko)
|
2014-06-02 |
2022-08-25 |
메디시노바, 인크. |
섬유증의 억제 또는 치료 방법
|
US9421793B2
(en)
|
2014-06-26 |
2016-08-23 |
Cellresin Technologies, Llc |
Electrostatic printing of cyclodextrin compositions
|
KR102462638B1
(ko)
|
2014-11-26 |
2022-11-03 |
메디시노바, 인크. |
이부딜라스트와 릴루졸의 배합물 및 이의 사용방법
|
EP3318252A1
(de)
*
|
2016-11-08 |
2018-05-09 |
Alpex Pharma SA |
Tablette mit verlängerter freisetzung mit einem arzneimittel zur gewichtsabnahme
|
CN111067906B
(zh)
*
|
2020-01-13 |
2022-09-09 |
苏州大学 |
美普他酚的应用
|
CA3217719A1
(en)
|
2021-05-28 |
2022-12-01 |
Kazuko Matsuda |
Phenoxyalkylcarboxylic acid derivatives and their use in lowering triglyceride levels
|